Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.63 |
| ▸ | ACHE | P22303 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 5/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.53 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | FASN | P49327 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL353943 | 0.86 | FASN (0.64) | CYP3A4ACHELMNAMEN1KMT2A | |
| SCHEMBL11482949 | 0.85 | KMT2A (0.50) | CYP3A4ACHELMNAMEN1KMT2A | |
| SCHEMBL7766611 | 0.84 | CYP3A4 (0.72) | CYP3A4ACHELMNAMEN1KMT2A | |
| SCHEMBL28689599 | 0.83 | CYP3A4 (0.61) | CYP3A4LMNAMEN1KMT2AGAA | |
| SCHEMBL12081977 | 0.82 | CYP3A4 (0.55) | CYP3A4ACHELMNAMEN1KMT2A | |
| SCHEMBL8619002 | 0.81 | BCL2L1 (0.54) | CYP3A4ACHELMNAMEN1KMT2A | |
| SCHEMBL11590335 | 0.80 | CYP3A4 (0.79) | CYP3A4ACHELMNAMEN1KMT2A | |
| Orsellinic Acid SCHEMBL522294 | 0.78 | CYP3A4 (1.00) | CYP3A4ACHELMNAMEN1KMT2A | |
| SCHEMBL28515130 | 0.78 | BCL2L1 (0.50) | CYP3A4LMNAMEN1KMT2AGAA | |
| SCHEMBL22658267 | 0.77 | SYNJ2 (0.69) | CYP3A4LMNAMEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160367521-A1 | XANTHONE-RICH PLANT EXTRACTS OR COMPOUNDS THEREFROM FOR MODULATING DISEASES OF THE CENTRAL NERVOUS SYSTEM AND RELATED DISORDERS | DEAKIN UNIVERSITY (AU) | 2016-12-22 | — | — | US | disclosed |
| US-5518851-A | BINDER, FLASH LIGHT FIXING | FUJITSU LIMITED (JP) | 1996-05-21 | — | — | US | disclosed |
| EP-0463822-B1 | Toner | FUJITSU LTD (JP) | 1996-03-13 | — | — | EP | disclosed |
| US-5389485-A | Void resistance, good fixability; for flash light fixing apparatus | FUJITSU LIMITED (JP) | 1995-02-14 | — | — | US | disclosed |
| EP-0463822-A2 | Toner | FUJITSU LIMITED (JP) | 1992-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160367521-A1 | XANTHONE-RICH PLANT EXTRACTS OR COMPOUNDS THEREFROM FOR MODULATING DISEASES OF THE CENTRAL NERVOUS SYSTEM AND RELATED DISORDERS | GAP43, PMP22, ACHE | CYP3A4 4057/4885ACHE 3/4885LMNA 647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.